Skip to main content
Erschienen in: Wiener Medizinische Wochenschrift 5-6/2017

01.04.2017 | case report

Undermining plastic surgery as a possible option for treating basal cell carcinoma of the forehead

verfasst von: Prof. Georgi Tchernev, Ivan Pidakev, PhD, Assoc. Prof. Ilia Lozev, MD, Prof. Dr. Torello Lotti, MD, MD (Hon), Jose Carlos Cardoso, MD, Prof. James W. Patterson, MD

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 5-6/2017

Einloggen, um Zugang zu erhalten

Summary

Basal cell carcinoma (BCC) is the most common cutaneous cancer. Although most cases can be cured with simple surgical procedures and are associated with a good prognosis, a minority of BCCs may pose significant therapeutic challenges. This occurs mostly in cases of so-called advanced BCC, which a loosely defined term that encompasses locally advanced lesions and tumors with metastatic spread. Treatment of these cases is often complex and sometimes may need combinations of therapeutic modalities, including surgery, radiotherapy and/or targeted therapy directed towards sonic hedgehog (SHH) signaling pathways, such as vismodegib. We herein present the case of a 74-year-old man presenting with a large basal cell of the forehead evolving for more than 7 years. The patient underwent excision of the lesion with clear surgical margins. Reconstruction of the defect was performed after extensive undermining of the skin allowing subsequent direct closure with a simple suture, which resulted in an acceptable cosmetic outcome. We discuss the potential advantages, disadvantages, and applicability of this relatively simple surgical maneuver in the reconstruction of defects resulting from excision of considerably large cutaneous tumors.
Literatur
1.
Zurück zum Zitat Wollina U, Tchernev G. Advanced basal cell carcinoma. Wien Med Wochenschr. 2013;163(15–16):347–53.CrossRefPubMed Wollina U, Tchernev G. Advanced basal cell carcinoma. Wien Med Wochenschr. 2013;163(15–16):347–53.CrossRefPubMed
2.
Zurück zum Zitat Hansel G, Tchernev G, Chokoeva AA, Lotti T, Schönlebe J, Wollina U. Failure of vismodegib in advanced Basal cell carcinoma. J Biol Regul Homeost Agents. 2015;29(1 Suppl):11–3.PubMed Hansel G, Tchernev G, Chokoeva AA, Lotti T, Schönlebe J, Wollina U. Failure of vismodegib in advanced Basal cell carcinoma. J Biol Regul Homeost Agents. 2015;29(1 Suppl):11–3.PubMed
3.
Zurück zum Zitat Mohan SV, Chang AL. Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep. 2014;3(1):40–5, eCollection 2014.CrossRefPubMedPubMedCentral Mohan SV, Chang AL. Advanced basal cell carcinoma: epidemiology and therapeutic innovations. Curr Dermatol Rep. 2014;3(1):40–5, eCollection 2014.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Tchernev G, Chokoeva AA, Penev PK, Ananiev J, Nowak A, Bayyoud Y, Philipov S, Cardoso JC, Wollina U. Relapsing advanced metatypical basal cell carcinomas (MTBCC) of the face: surgical modalities. Wien Med Wochenschr. 2014;164(23–24):529–35.CrossRefPubMed Tchernev G, Chokoeva AA, Penev PK, Ananiev J, Nowak A, Bayyoud Y, Philipov S, Cardoso JC, Wollina U. Relapsing advanced metatypical basal cell carcinomas (MTBCC) of the face: surgical modalities. Wien Med Wochenschr. 2014;164(23–24):529–35.CrossRefPubMed
Metadaten
Titel
Undermining plastic surgery as a possible option for treating basal cell carcinoma of the forehead
verfasst von
Prof. Georgi Tchernev
Ivan Pidakev, PhD
Assoc. Prof. Ilia Lozev, MD
Prof. Dr. Torello Lotti, MD, MD (Hon)
Jose Carlos Cardoso, MD
Prof. James W. Patterson, MD
Publikationsdatum
01.04.2017
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 5-6/2017
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-017-0542-x

Weitere Artikel der Ausgabe 5-6/2017

Wiener Medizinische Wochenschrift 5-6/2017 Zur Ausgabe